Zavante Therapeutics is a company that provides Epoxide, Medicine, Health care and more. Zavante Therapeutics is headquartered in United States California. Zavante Therapeutics was founded in 2015. and was founded by Ted Schroeder. Zavante Therapeutics has a total of 12 patents
Related Topics
EpoxideMedicineHealth carePharmacy and TherapeuticsAntibiotic resistanceFidaxomicinCeftaroline fosamilCeftolozaneInfection drugHospital-acquired pneumoniaTelavancinRifampicinOritavancinAvibactamAntibacterial Drug ResistanceCeftazidime/avibactamDalbavancinImipenemCilastatinSolithromycin
visualizing technology portfolio of hot application areas and blank areas for Zavante Therapeutics
Time Range:
Overall
Overall
1 year
3 year
5 year
Application Domain L2
Application Domain L2
Application Domain L3
Application Domain L4
High-Tech Industry L1
High-Tech Industry L2
Tech Topic L2
Tech Topic L3
Timeline
Tech Topic L2
Tech Topic L2
Tech Topic L3
High-Tech Industry L1
High-Tech Industry L2
Application Domain L2
Application Domain L3
Application Domain L4
Download
Subsidiary Lists
Subsidiaries with patent applications for Zavante Therapeutics
Sign up to view the full data
Free Trial Now
Download
Zavante Therapeutics Frequently Asked Questions
What is Zavante Therapeutics's industry?
Zavante Therapeutics is in the industry of:Pharmaceutical and Medicine Manufacturing
What technical fields has Zavante Therapeutics researched?
Zavante Therapeutics has researched the technical fields related toEpoxideMedicineHealth carePharmacy and TherapeuticsAntibiotic resistanceFidaxomicinCeftaroline fosamilCeftolozaneInfection drugHospital-acquired pneumoniaTelavancinRifampicinOritavancinAvibactamAntibacterial Drug ResistanceCeftazidime/avibactamDalbavancinImipenemCilastatinSolithromycin
What is Zavante Therapeutics's total number of patents?